Newsletter

Below is an important message from one of our highly valued partners and today's top news.

What to know about Trump's buyout proposal for federal employees

President Donald Trump's administration is offering to federal employees to quickly reduce the government workforce. They don't have a long time to decide: The deadline is Feb. 6. More Info ➔

The $20 Stock Powering NVIDIA, TESLA, and Microsoft - Ad

The biggest AI firms in the world... All rely on this single company. And right now, you can get in for only $20 - but not for long. Take Action Now >>>

Shipments of uranium ore can resume under agreement reached with the Navajo Nation

Shipments of uranium ore from just south of the Grand Canyon are expected to resume in February after the Navajo Nation reached a settlement with the mining company, clearing the way for trucks to transport the ore across the largest Native American reservation in the U.S. More Info ➔

Donald and Melania Trump Memecoins Outgain Bitcoin, Ethereum Amid Market Lull -- Analyst Says TRUMP Bottomed Out At $25

President Donald Trump‘s meme coin outperformed the broader cryptocurrency market with a double-digit surge on Monday. What happened: The Official Trump (TRUMP) token surged over 10% in the last 24 hours, reaching a market valuation of $5.92 billion and a fully diluted value of $29.62 billion. More Info ➔

Donald Trump to Repeal Joe Biden's AI Executive Order - Ad

This will open the floodgates! Once Donald Trump takes this decisive action, it will ignite a second wave of euphoria in AI stocks. And one company -- founded by Elon Musk, Trump's right-hand man and most trustworthy advisor -- is in the prime position to profit. (Hint: It's NOT Tesla). Get the full story today.

Datadog Faces Revenue And Margin Headwinds In 2025, Analyst Downgrades Stock

Stifel analyst Brad Reback downgraded Datadog from Buy to Hold and lowered its price target to $140, citing concerns over modest growth despite a contract renewal with OpenAI. More Info ➔

What's Going On With Manhattan Associates Shares Wednesday?

Manhattan Associates shares are trading lower on Wednesday after the company announced soft guidance for the 2025 fiscal-year. More Info ➔

Is Bill Gates Missing the Big Picture? - Ad

Bill Gates calls it: "The most transformative technology any of us will see in our lifetimes." Eric Fry agrees, saying it's far more advanced than anything today... including AI. But he also warns it could send millions of Americans into poverty. Take these 3 steps to prepare.

Trump's Commerce Secretary nominee, Howard Lutnick, vows to sell his business interests in 90 days

WASHINGTON (AP) — Billionaire financier Howard Lutnick, President Donald Trump's choice to lead the Commerce Department, said Wednesday that he would sell all of his business holdings within 90 days. More Info ➔

AI ETFs In Focus As Alibaba Challenges DeepSeek With New Model

AI arms race fueled by DeepSeek and Alibaba's AI models. Investors can profit from trend with AI-focused ETFs, including AIQ, ARKQ, QQQ. More Info ➔

Bitcoin's Final Bull Run: Three Altcoins to Get Into NOW! - Ad

"Crypto Whisperer" Ian King is calling it: due to a change in Bitcoin's "status," he believes Bitcoin is about to go on one FINAL bull run. But the best way to play it isn't by buying Bitcoin. Instead, Ian has identified 3 specific "alt" coins with the potential to blow past Bitcoin's spectacular gains. To get in before April 19th, see everything you need to do HERE now.

FireAid, with Billie Eilish and Lady Gaga, is the latest in a long line of massive benefit concerts

Billie Eilish, Sting, Red Hot Chili Peppers and others in a efforts, is the latest event to combine music and philanthropy. More Info ➔

7 AI Infrastructure Stocks Plunge Over 20%, Outpace Semiconductor Rout As DeepSeek Upends Investment Landscape

The launch of DeepSeek affects the AI boom including the power, cooling and data center giants that once rode the AI euphoria, which now have single-day losses exceeding 20%. More Info ➔

Ozempic Receives FDA Approval To Treat Kidney Disease

The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease in patients who also have type 2 diabetes. More Info ➔

3 ETFs Shine As Trump's First Week Sparks Record Gains Followed By Tech Slump

The S&P 500 had a strong first week, with ETFs such as SPY, VOO and IVV seeing gains. Were Trump's economic policies a factor? More Info ➔

Dan Ives Expects Meta And Microsoft To Stand Firm On $60 - $80 Billion AI Spending Plans Amid DeepSeek's Disruptive AI Model

Wedbush Securities analyst Dan Ives expects Meta Platforms Inc. and Microsoft Corp. to stand firm on their ambitious artificial intelligence spending plans during their upcoming earnings calls, despite recent market jitters over Chinese AI startup DeepSeek's emergence. More Info ➔

Stock market today: Asia shares mostly rise while some regional markets stay closed for holidays

TOKYO (AP) — Asian shares mostly rose Thursday after the U.S. Federal Reserve opted for the first time since it began trying to help through easier rates in September. More Info ➔

Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

339-20 De Boers Dr., Toronto, ON M3J 0H1, 917.672.7040
© 2025 Musth | MarketHundred | All rights reserved.

Unsubscribe